These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7547422)

  • 1. Serum lipoprotein (a) levels in Behçet's disease.
    Seçkin D; Akpolat T; Oltulu Y; Erkan D; Cantürk T; Adam B; Turanli AY
    Br J Dermatol; 1995 Aug; 133(2):342-3. PubMed ID: 7547422
    [No Abstract]   [Full Text] [Related]  

  • 2. High lipoprotein (a) levels as a thrombogenic risk factor in Behçet's disease.
    Orem A; Değer O; Memiş O; Calişkan K; Cimşit G
    Ann Rheum Dis; 1994 May; 53(5):351-2. PubMed ID: 8017992
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein (a) in Behçet's disease as an indicator of disease activity and in thrombotic complications.
    Gürbüz O; Ozdemir Y; Coşar CB; Kural G
    Eur J Ophthalmol; 2001; 11(1):62-5. PubMed ID: 11284488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications.
    Esmat S; El Sherif H; Anwar S; Fahmy I; Elmenyawi M; Shaker O
    Eur J Dermatol; 2006; 16(1):67-71. PubMed ID: 16436346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events.
    Erem C; Uslu T; Deger O; Tosun M; Kavgaci H
    Heart; 2000 Aug; 84(2):208-9. PubMed ID: 10908264
    [No Abstract]   [Full Text] [Related]  

  • 6. Three risk factors--high lipoprotein (a), elevated FVIII, and FV Leiden--in a pediatric Behçet's disease patient with deep vein thrombosis.
    Gözdaşoğlu S; Uysal Z; Ertem M; Akar N
    Thromb Res; 2002 May; 106(4-5):263. PubMed ID: 12297135
    [No Abstract]   [Full Text] [Related]  

  • 7. Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease.
    Orem A; Değer O; Memiş O; Bahadir S; Ovali E; Cimşit G
    Ann Rheum Dis; 1995 Sep; 54(9):726-9. PubMed ID: 7495343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Lipoprotein(a) and its relationship with disease activity in patients with Behçet's disease.
    Orem A; Değer O; Cimşit G; Karahan SC; Akyol N; Yildirmiş S
    Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):473-8. PubMed ID: 8547429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoprotein (a) levels and Behçet's disease: is there an association?
    Balik O; Gur G; Lenk N; Artuz F; Alli N
    Int J Dermatol; 2007 Aug; 46(8):827-9. PubMed ID: 17651165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum E-selectin and beta 2-microglobulin levels in Behçet's disease.
    Karakuzu A; Aktaş A; Akçay F
    J Int Med Res; 2002; 30(1):85-8. PubMed ID: 11921504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity.
    Evereklioglu C; Inalöz HS; Kirtak N; Doganay S; Bülbül M; Ozerol E; Er H; Ozbek E
    Br J Dermatol; 2002 Aug; 147(2):331-6. PubMed ID: 12174107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.
    Orem A; Cimşit G; Değer O; Vanizor B; Karahan SC
    Dermatology; 1999; 198(3):243-6. PubMed ID: 10393445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid profile and anticardiolipin antibodies in Behcet's disease.
    Musabak U; Baylan O; Cetin T; Yesilova Z; Sengul A; Saglam K; Inal A; Kocar IH
    Arch Med Res; 2005; 36(4):387-92. PubMed ID: 15950080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
    Chekaoui A; Lahmar K; Belguendouz H; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
    Eur Cytokine Netw; 2018 Sep; 29(3):95-102. PubMed ID: 30547891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum zinc, copper and magnesium in Behçet's disease.
    Cengiz K; Gürkaynak F
    Mater Med Pol; 1988; 20(3):190-3. PubMed ID: 3244293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.